These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23247613)

  • 1. Immunotherapy in prion disease.
    Roettger Y; Du Y; Bacher M; Zerr I; Dodel R; Bach JP
    Nat Rev Neurol; 2013 Feb; 9(2):98-105. PubMed ID: 23247613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
    Vana K; Zuber C; Nikles D; Weiss S
    Cell Mol Neurobiol; 2007 Feb; 27(1):107-28. PubMed ID: 17151946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for prion diseases: opportunities and obstacles.
    Li L; Napper S; Cashman NR
    Immunotherapy; 2010 Mar; 2(2):269-82. PubMed ID: 20635933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain variation in treatment and prevention of human prion diseases.
    Ellett LJ; Revill ZT; Koo YQ; Lawson VA
    Prog Mol Biol Transl Sci; 2020; 175():121-145. PubMed ID: 32958230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches targeting the prion receptor LRP/LR.
    Zuber C; Ludewigs H; Weiss S
    Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmissible spongiform encephalopathies of livestock.
    Greenlee JJ; Greenlee MH
    ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transmissible spongiform encephalopathies (prion diseases): a review for dental surgeons.
    Gill DS; Tredwin CJ; Gill SK; Ironside JW
    Int Dent J; 2001 Dec; 51(6):439-46. PubMed ID: 11789711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.
    Diaz-Espinoza R; Morales R; Concha-Marambio L; Moreno-Gonzalez I; Moda F; Soto C
    Mol Psychiatry; 2018 Mar; 23(3):777-788. PubMed ID: 28630454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization delays the onset of prion disease in mice.
    Sigurdsson EM; Brown DR; Daniels M; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Am J Pathol; 2002 Jul; 161(1):13-7. PubMed ID: 12107084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of prion disease therapeutics.
    Forloni G; Roiter I; Tagliavini F
    Curr Opin Pharmacol; 2019 Feb; 44():53-60. PubMed ID: 31108459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.
    Caramelli M; Ru G; Acutis P; Forloni G
    CNS Drugs; 2006; 20(1):15-28. PubMed ID: 16396521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.
    Bade S; Frey A
    Expert Rev Vaccines; 2007 Apr; 6(2):153-68. PubMed ID: 17408366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of Animal Prion Diseases.
    Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anesthesia and non-conventional transmissible agents (or prion diseases)].
    Estèbe JP
    Ann Fr Anesth Reanim; 1997; 16(8):955-63. PubMed ID: 9750644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine approaches to prevent and treat prion infection : progress and challenges.
    Müller-Schiffmann A; Korth C
    BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the transmissible spongiform encephalopathies: prion protein disorders.
    DeArmond SJ
    Br Med Bull; 1993 Oct; 49(4):725-37. PubMed ID: 8137126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination strategies.
    Wisniewski T; Goñi F
    Handb Clin Neurol; 2018; 153():419-430. PubMed ID: 29887149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions: a mystery unravelled?
    Cavallo G; Lembo D; Cavallo R
    Riv Biol; 2010; 103(2-3):343-70. PubMed ID: 21384329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.